This is the authors' abstract. We don't add key points for this paper.
In this work, Morgenstern and colleagues describe an approach involving functionalized nanobodies which decrease the activity of voltage-gated Ca2+ channels associated with β1 subunits and promote their removal from the surface membrane of neurons and muscle.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Manning et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: